Back to search

National and Kapodistrian University of Athens

Μηχανισμοί καταστροφής των επιθηλιακών κυττάρων σε αυτοάνοσες οργανοειδικές νόσους

Abstract

dc:description

The aim of these studies was to identify molecules involved in the pathogenesis of Sjogren’s syndrome (SS). Firstly, immunohistochemistry was performed in minor salivary gland (MSG) biopsies from patients with SS in order to identify the expression of different apoptosis-related proteins. The purpose of this approach was to clarify the mechanism of epithelial cell destruction in MSG biopsies of patients with SS. Epithelial cells of patients expressed the apoptotic proteins Fas, Fas-Ligand and Bax and were susceptible to apoptotic death as it was shown by the TUNEL assay. On the other hand, the mononuclear infiltrating cells expressed Fas-Ligand, Bcl-2, Perforin and Granzyme-B. Due to Bcl-2 expression the mononuclear infiltrating cells were resistant to apoptosis while they induced epithelial cell apoptosis through Perforin and Granzyme-B expression. Finally, epithelial cells of patients expressed the regenerative protein pS2 as a possible defensive mechanism against apoptotic destruction. Secondly, the expression of p53 and p21 in MSG biopsies of patients with SS was examined. These studies were performed by immunohistochemistry and Western blot and revealed increased expression of these proteins in MSGs of patients as compared to control individuals. The next step was to isolate genomic DNA from patients with SS as well as patients with SS and in situ non-Hodgkin’s lymphoma in order to perform PCR amplification of the p53 gene and sequence analysis. The p53 gene in patients with SS was wild type suggesting a possible existence of a DNA damaging agent in the exocrine glands of patients leading to p53 and p21 gene activation in order to facilitate DNA repair mechanisms. On the other hand, patients with SS and in situ non-Hodgkin’s lymphoma revealed two novel mutations on the DNA-binding domain of the p53 gene. These were point mutations and produced amino-acid substitutions. It is most likely that due to these mutations the p53 gene loses its ability to safeguard the cell cycle leading this way to uncontrolled cell proliferation and lymphoma development. The next step of our studies was to perform differential gene-display analysis so as to identify genes that participate in the pathogenesis of the disease. A MSG biopsy from a patient with primary SS and one from a control individual were used as the starting material. Total RNA was isolated from these samples to perform a differential display protocol with eight different random pairs of oligonucleotide primers. Severaldifferentially expressed genes were isolated, reamplified and cloned for sequence analysis. Sequences were compared with the Gene bank sequence-database. One clone had 98% homology with the human CRISP-3 gene. The CRISP gene family consists of three members (CRISP-1, 2, 3); they were originally isolated from male mice while in humans they are expressed in the male genital tract and the male salivary glands. The expression of the CRISP-3 gene is under the restricted control of androgens. Since women with SS have an androgen deficiency while there was still no evidence about the function of the CRISP-3 gene; an activation of the gene through immune-mediated activation pathways was suspected. In order to prove this hypothesis we firstly performed a RT-PCR in RNA samples from four patients with SS and two controls and found that only SS patients expressed the CRISP-3 gene. Secondly, in vitro transcription was employed to create RNA probes for in situ hybridization revealing that the CRISP-3 transcripts were expressed mainly by the mononuclear cells infiltrating the MSGs of patients with SS. The next step was to isolate normal peripheral blood lymphocytes (PBLs) and activate them in culture in order to identify CRISP-3 gene expression. Several PBL activators were used (PMA, PHA, ionomycin, a-CD3, a-CD28) in different time-periods (t: 0, t: 6, t: 12, t: 24, t: 48). Total RNA was isolated from these cells to perform RT-PCR that revealed that CRISP-3 gene was expressed only in PMA-treated cells after 6 hours in culture. Trying to identify the signaling pathway leading to CRISP-3 gene activation PBLs were activated with PMA in different time periods (t: 30min, t: 1h, t: 3hrs, t: 6hrs) while other PBLs were treated with PMA and Staurosporine to inhibit the PKC signaling. These experiments revealed that the CRISP-3 gene is an early-transcribed gene (between 30min and 6 hrs.) while PKC mediates this expression since the addition of Staurosporine downregulated CRISP-3 gene activation. Finally, the coding region of the CRISP-3 gene was introduced into the pIRES2-EGFP vector and used to transfect BJAB B-cells. Transfected cells lost the typical round shape of B cells and became more elongated like B cells at the terminal phase of their differentiation. Flow cytometric analysis showed that CRISP-3 is capable of inducing the expression of HLA-DR, CD20 and CD25 on the surface of transfected cells. These results implicated CRISP-3 in B-cell activation and differentiation pathways. In MSGs of patients with SS the CRISP-3 gene may be activated in the concept of the polyclonal activation of infiltrating B cells. As an early-response gene it may participate in B cell activation perpetuating the autoimmune B cell reaction in the lesion. These speculations are still under experimentation.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2002

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Tapinos, Nikolaos
  • Ταπεινός, Νικόλαος

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/24178

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Tapinos, Nikolaos; Ταπεινός, Νικόλαος. Μηχανισμοί καταστροφής των επιθηλιακών κυττάρων σε αυτοάνοσες οργανοειδικές νόσους. National and Kapodistrian University of Athens, 2002. http://hdl.handle.net/10442/hedi/24178